Brief

last 24h

[2/2] 224 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

TOOL · 36氪 (36Kr) 中文(ZH) · 5h

Yipin Hong: Wholly-owned subsidiary's innovative drug APH03867 tablets receive clinical trial registration application acceptance

Yipin Hong's subsidiary, Guangzhou Yipin Hong Pharmaceutical Co., Ltd., has received acceptance from the National Medical Products Administration for its clinical trial application for the innovative drug APH03867. This marks a significant step in the drug's development process. Separately, Shanghai Yancheng Trading Co., Ltd. saw changes in its leadership, with Kelly Zong appointed as the legal representative and manager, and Zhejiang Hongyi Holding Group Co., Ltd. as the sole shareholder. AI
COMMENTARY · 36氪 (36Kr) 中文(ZH) · 6d

Zong Fuli Appointed Legal Representative of Hangzhou Hongsheng Hengfeng

A fire broke out in the gas room of SK Hynix's M15X facility in Cheongju, South Korea, marking the second incident this month. The fire was quickly contained by the building's sprinkler system, and no injuries or gas leaks have been reported. The company is investigating the cause and potential impact on production. Separately, Zong Fuli has taken over as the legal representative for Hangzhou Hongshenghengfeng Trading Co., Ltd., a company involved in food sales and logistics. AI

Yipin Hong: Wholly-owned subsidiary's innovative drug APH03867 tablets receive clinical trial registration application acceptance